NFKB1 and neoplasm: NF-κB activation can be mediated both by signaling pathways of Toll-like receptor TLR-MYD88 and the previously mentioned inflammatory cytokines TNFα and IL-1β [316,317,318], as well as genetic changes in tumor cells [319].